CLSA analyst Michael Luo upgraded Charles River Labs (NYSE: CRL) from Hold (3) to Outperform (2) with a price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE